Methadone Clinics in Pennsylvania

Methadone clinics in Pennsylvania provide helpful resources for those suffering from potentially deadly opiate addictions. Heroin & prescription painkillers continue to cause serious problems throughout Pennsylvania but with the help of Methadone maintenance treatment, many residents have found a way to get sober.

Methadone Clinics in cities of Pennsylvania

Finding medication treatment for opioid use disorder in Pennsylvania

Pennsylvania is one of the harder-hit states in the country for opioid use disorder, and also one of the more organized in its response. The Commonwealth has built a layered system over the past decade: federally certified opioid treatment programs in most metro areas, a growing network of office-based buprenorphine prescribers, statewide telehealth access, hospital emergency departments trained to start medication on the spot, and a designated Center of Excellence program that ties care coordination to your Medicaid plan. The listings above show providers near you. The sections below explain what the medications are, how Pennsylvania pays for them, and how to get started this week.

The three medications and where each one is available

There are three FDA-approved medications for opioid use disorder, and the setting depends on the medication.

Methadone for opioid use disorder is provided only through licensed opioid treatment programs (OTPs), not regular pharmacies. The OTP is where you go for the dose, daily at first, with take-home doses earned over time. Methadone is the medication with the longest track record and is often the strongest fit for someone coming off high-potency fentanyl.

Buprenorphine, including Suboxone (a buprenorphine-naloxone film or tablet) and the monthly extended-release injection Sublocade, can be prescribed in a doctor’s office and filled at a pharmacy, or provided through a clinic. This is office-based opioid treatment (OBOT). It is the most flexible option and the one most widely available in rural Pennsylvania.

Naltrexone, including the monthly Vivitrol injection, can be prescribed by a licensed provider, but treatment starts only after a person has stopped using opioids for a set time. It is not an opioid itself; it blocks the effect. Choosing among the three is a conversation with a clinician about your situation, history, and preferences, and you can read how methadone and Suboxone compare in everyday use before that call.

How Pennsylvania’s system is built: Medical Assistance, Centers of Excellence, and SCAs

Two things make Pennsylvania’s access picture distinct, and both are worth knowing before you call anyone.

First, Pennsylvania’s Medicaid program is called Medical Assistance, delivered through HealthChoices managed care. Behavioral health services, including all medications for opioid use disorder, are carved out to a separate Behavioral Health Managed Care Organization (BH-MCO) tied to your county. Medical Assistance covers methadone, buprenorphine, and naltrexone with no copay, and the Medical Assistance Transportation Program (MATP) will get you to a methadone clinic or pharmacy if you need a ride.

Second, the state launched the Centers of Excellence (COE) program in 2016, with 45 designated centers across the Commonwealth. A COE is not a treatment facility on its own; it is a hospital, FQHC, primary care practice, or SUD provider with a community-based care management team that coordinates whole-person treatment. The Pennsylvania Department of Human Services reported in 2020 that more than 30,000 Pennsylvanians had accessed care through a COE since the program began. In 2024, DHS designated Ophelia as the state’s first virtual-first COE, extending the model to telehealth for rural and Medicaid populations.

If you do not have insurance, the state-funded path runs through your county’s Single County Authority (SCA). The Pennsylvania Department of Drug and Alcohol Programs (DDAP) funds 47 SCAs that arrange and pay for treatment for uninsured and underinsured residents. DDAP also operates the Get Help Now hotline, staffed 24/7, that can connect you to your county SCA or a treatment provider directly.

Pennsylvania’s overdose picture, and why this matters now

The Pennsylvania Department of Health reported 4,719 overdose deaths in 2023, 83 percent of them opioid-related and roughly 77 percent involving fentanyl. The state has also seen a real decline: statewide drug overdose deaths fell from 4,415 in 2018 to 3,341 in 2024, a 29 percent drop, according to provisional figures cited by the harm-reduction organization NEXT Distro and consistent with CDC data showing every state moving below its overdose peak by 2024 (KFF analysis of CDC WONDER, 2026).

Public-health officials credit several factors: wider availability of naloxone, a shift in the street drug supply, and more treatment access, including buprenorphine started in emergency departments. Fentanyl is still by far the dominant driver of fatal overdoses in Pennsylvania, and xylazine adulteration has complicated wound care and withdrawal. The decline is real, and so is the ongoing risk. If you use any opioid in Pennsylvania today, the safest step is to carry naloxone and to consider medication treatment sooner rather than later.

How to start treatment in Pennsylvania this week

You have more than one door, and the right one depends on your situation. For methadone, call an opioid treatment program directly from the listings above; OTPs handle their own intake assessments, and federal rules updated in 2024 removed older barriers (including the prior requirement that you have a one-year history of opioid addiction) so it is easier to be admitted. For buprenorphine or Suboxone, you can call an office-based prescriber, a Center of Excellence, a federally qualified health center, or a telehealth provider. As of June 2026, buprenorphine can be started by telehealth in Pennsylvania, including by phone in many cases, without a prior in-person visit; current federal telehealth flexibilities run through the end of 2026 and are still being finalized, so confirm your options with the provider.

If you are in withdrawal right now and not sure where to go, three options work: call the DDAP Get Help Now line for routing to your county SCA, walk into a hospital emergency department (Pennsylvania funds the Opioid Hospital Quality Improvement Program, which trains hospitals across the Commonwealth to start buprenorphine at the bedside and arrange a warm handoff to ongoing care), or use the helpline listed on this page. Starting Suboxone too soon after using fentanyl can trigger sudden, severe withdrawal (precipitated withdrawal), so the timing of the first dose is something a clinician plans with you; this is not a reason to wait, just a reason to be honest about your last use. For a closer look at what the first weeks look like, see how methadone treatment works for fentanyl use and when inpatient care fits versus outpatient.

Special situations: pregnancy, the postpartum period, and reentry from incarceration

Pennsylvania’s Maternal Mortality Review Committee found in its 2024 and 2025 annual reports that mental health conditions, including substance use disorder, remain leading causes of pregnancy-related deaths in the state. Methadone and buprenorphine are the recommended standard of care during pregnancy, and continuing medication is safer for both parent and infant than stopping. Hospitals across Pennsylvania use the Eat, Sleep, Console model for managing neonatal opioid withdrawal syndrome (NOWS), which keeps parent and infant together when possible. PA Perinatal TiPS, a Department of Health program, provides curbside consultation to obstetricians, midwives, and primary care providers caring for pregnant and postpartum patients with opioid use disorder, regardless of the patient’s insurance. Plain answers about methadone during pregnancy are available, and guidance for families covers what loved ones can do to help.

For people leaving Pennsylvania jails and state prisons, continuity of medication treatment is increasingly common but varies by county and facility. Ask the reentry coordinator or your SCA about a same-week handoff. Pennsylvania’s COE program was built in part to bridge transitions like this one, with care managers who can pick up the case quickly.

Naloxone access in Pennsylvania

Naloxone, the medication that reverses an opioid overdose, is widely available across the Commonwealth. Narcan nasal spray is sold over the counter at most pharmacies, and Pennsylvania’s statewide standing order, signed by the Physician General, lets any pharmacy dispense naloxone without an individual prescription. Pennsylvania’s Act 139, also called the Good Samaritan Law or David’s Law, gives criminal immunity protections to people who call 911 to report an overdose and stay with the person until help arrives. Free naloxone by mail is available through NEXT Distro for Pennsylvania residents, and the Pennsylvania Overdose Prevention Program (POPP) supplies free naloxone and fentanyl and xylazine test strips to organizations and community groups statewide. If cost is a barrier, the Pennsylvania Department of Aging Co-Pay Assistance Program reimburses up to $50 toward a pharmacy purchase. More on how to recognize and respond to an overdose is worth reading once for everyone in the household, not just the person in treatment.

Common questions about MOUD in Pennsylvania

Does Medical Assistance cover all three medications?

Yes. Pennsylvania Medical Assistance covers methadone, buprenorphine (including Suboxone and Sublocade), and naltrexone (including Vivitrol). Behavioral health services run through a county-based Behavioral Health Managed Care Organization under HealthChoices. Some products may require prior authorization through the statewide Preferred Drug List, which your provider’s office handles.

Can I start Suboxone by telehealth in Pennsylvania?

In most cases, yes. As of June 2026, federal flexibilities allow buprenorphine to be started by telehealth, including by phone, without a prior in-person visit; those flexibilities are scheduled to continue through the end of 2026. A permanent federal rule for buprenorphine telemedicine is also in effect with somewhat different requirements. State law also applies, so confirm with the provider you call.

What is a Center of Excellence and do I need one?

A COE is a designated provider with a community-based care management team that coordinates your treatment alongside primary care, behavioral health, and social services like housing or transportation. You do not have to use a COE to get medication, but if you have Medical Assistance and you want help navigating the system, asking your BH-MCO for a COE referral is a reasonable starting point.

How do I get methadone if I do not have insurance?

Call your county’s Single County Authority. The SCA can pay for treatment for residents without insurance through DDAP funding. The DDAP Get Help Now line can connect you to your county’s SCA at any hour.

What if I need to transfer my methadone treatment from another state or program?

Most Pennsylvania opioid treatment programs accept transfers and can arrange guest dosing for short trips, with documentation from your current program. Under federal rules updated in 2024, take-home methadone can extend up to a 28-day supply for stable patients, decided by the program based on your treatment progress. Long-term methadone treatment looks different now than it did even three years ago.

Can my employer find out I am in treatment?

Treatment records held by federally assisted substance use programs are protected by 42 CFR Part 2, a stricter federal confidentiality rule than HIPAA. More on workplace and privacy questions covers what is and is not disclosable.

Sources and review

Last reviewed June 2026.

Sources used on this page:

Pennsylvania Department of Health, Opioids data and Naloxone information (pa.gov), 2023 fatal overdose surveillance.
Pennsylvania Department of Human Services, Centers of Excellence program (pa.gov).
Pennsylvania Department of Drug and Alcohol Programs, Get Help Now and Naloxone (ddap.pa.gov).
Pennsylvania Department of Health, PA Perinatal TiPS (pa.gov).
SAMHSA, 42 CFR Part 8 final rule (2024) and Buprenorphine Telemedicine Prescribing.
DEA and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities, Federal Register, December 31, 2025.
KFF analysis of CDC WONDER, Opioid Overdose Deaths: National Trends and Variation by Demographics and States, February 2026.
NEXT Distro, Pennsylvania overdose figures and naloxone-by-mail program (nextdistro.org).

Methadone Centers is a treatment-discovery and education platform. We are not a treatment provider and do not provide medical advice. Information on this page is for general education and is not a substitute for an evaluation by a licensed clinician.

The helpline displayed on this site is answered by a paid sponsor. Calls to the helpline are confidential. You can also contact the Pennsylvania Department of Drug and Alcohol Programs Get Help Now line or SAMHSA’s National Helpline directly.